The Asia Pacific Spine Bone Stimulators Market is expected to witness market growth of 4.7% CAGR during the forecast period (2022-2028).
Surgically inserting titanium, titanium-alloy, stainless steel, or non-metallic substances into the spine is known as spinal instrumentation. The spine is a long-term solution for spinal instability. Medical implants are available in a wide range of shapes, sizes, and designs, all of which are intended to cure spinal problems in persons of different ages. Spondylolisthesis, degenerative disc degeneration, and other spinal anomalies are treated with spine bone stimulators devices. The market is expanding due to an increase in the older population and the frequency of spinal illnesses.
Fractures, trauma, deformity, tumors, and degenerative diseases can all cause the spinal system to become unstable. Aside from these reasons, a blocked blood supply, traumas, infections, and compression caused by a tumor or shattered bone can all result in spinal cord injury. Spine bone stimulators devices give stability when the spinal system loses strength due to the disorders listed above. In recent years, the market for spine bone stimulators devices has profited from a rise in the occurrence of spinal cord injuries.
Asia Pacific has a considerable market for spine bone stimulator devices due to an increase in the prevalence of spinal disorders and higher healthcare spending. Furthermore, the rapidly aging population, as well as the cheaper cost of spinal procedures in developing countries such as India compared to affluent countries, has increased the demand for spinal implants. Significant institutions in India do spinal surgery, including numerous multi-faculty spinal surgery facilities and super-specialty hospitals that perform complex and sophisticated surgeries like microscopic spine surgery. The desire for spine bone stimulators is predicted to rise as a result of the aforementioned difficulties.
The demand for spinal arthrodesis devices is likely to increase throughout the forecast period, owing to favorable reimbursement for spine operations and the increased frequency of degenerative diseases and spine fractures in the Asia Pacific. In September 2019, the Australian government announced changes to the Medicare Benefits Schedule (MBS) items for spine procedures, ensuring that patients who have spinal surgery are properly reimbursed. This is expected to help the Asia Pacific market grow even further.
The China market dominated the Asia Pacific Spine Bone Stimulators Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $49.5 million by 2028. The Japan market is experiencing a CAGR of 4.1% during (2022 - 2028). Additionally, The India market is expected to exhibit a CAGR of 5.3% during (2022 - 2028).
Based on Device Type, the market is segmented into Non-Invasive and Invasive. Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DJO Global, Inc. (Enovis), Zimmer Biomet, Orthofix Medical Inc., Elizur Corporation, Ossatec Benelux BV, IGEA S.p.A., ManaMed Inc., Theragen, Inc., Intelligent Implants, and Orchid Medical, Inc
Surgically inserting titanium, titanium-alloy, stainless steel, or non-metallic substances into the spine is known as spinal instrumentation. The spine is a long-term solution for spinal instability. Medical implants are available in a wide range of shapes, sizes, and designs, all of which are intended to cure spinal problems in persons of different ages. Spondylolisthesis, degenerative disc degeneration, and other spinal anomalies are treated with spine bone stimulators devices. The market is expanding due to an increase in the older population and the frequency of spinal illnesses.
Fractures, trauma, deformity, tumors, and degenerative diseases can all cause the spinal system to become unstable. Aside from these reasons, a blocked blood supply, traumas, infections, and compression caused by a tumor or shattered bone can all result in spinal cord injury. Spine bone stimulators devices give stability when the spinal system loses strength due to the disorders listed above. In recent years, the market for spine bone stimulators devices has profited from a rise in the occurrence of spinal cord injuries.
Asia Pacific has a considerable market for spine bone stimulator devices due to an increase in the prevalence of spinal disorders and higher healthcare spending. Furthermore, the rapidly aging population, as well as the cheaper cost of spinal procedures in developing countries such as India compared to affluent countries, has increased the demand for spinal implants. Significant institutions in India do spinal surgery, including numerous multi-faculty spinal surgery facilities and super-specialty hospitals that perform complex and sophisticated surgeries like microscopic spine surgery. The desire for spine bone stimulators is predicted to rise as a result of the aforementioned difficulties.
The demand for spinal arthrodesis devices is likely to increase throughout the forecast period, owing to favorable reimbursement for spine operations and the increased frequency of degenerative diseases and spine fractures in the Asia Pacific. In September 2019, the Australian government announced changes to the Medicare Benefits Schedule (MBS) items for spine procedures, ensuring that patients who have spinal surgery are properly reimbursed. This is expected to help the Asia Pacific market grow even further.
The China market dominated the Asia Pacific Spine Bone Stimulators Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $49.5 million by 2028. The Japan market is experiencing a CAGR of 4.1% during (2022 - 2028). Additionally, The India market is expected to exhibit a CAGR of 5.3% during (2022 - 2028).
Based on Device Type, the market is segmented into Non-Invasive and Invasive. Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DJO Global, Inc. (Enovis), Zimmer Biomet, Orthofix Medical Inc., Elizur Corporation, Ossatec Benelux BV, IGEA S.p.A., ManaMed Inc., Theragen, Inc., Intelligent Implants, and Orchid Medical, Inc
Scope of the Study
Market Segments Covered in the Report:
By Device Type
- Non-Invasive
- Invasive
By End User
- Hospitals
- Specialty Clinics
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- DJO Global, Inc. (Enovis)
- Zimmer Biomet
- Orthofix Medical Inc.
- Elizur Corporation
- Ossatec Benelux BV
- IGEA S.p.A.
- ManaMed Inc.
- Theragen, Inc.
- Intelligent Implants
- Orchid Medical, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Asia Pacific Spine Bone Stimulators Market by Device Type
Chapter 5. Asia Pacific Spine Bone Stimulators Market by End User
Chapter 6. Asia Pacific Spine Bone Stimulators Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- DJO Global, Inc. (Enovis)
- Zimmer Biomet
- Orthofix Medical Inc.
- Elizur Corporation
- Ossatec Benelux BV
- IGEA S.p.A.
- ManaMed Inc.
- Theragen, Inc.
- Intelligent Implants
- Orchid Medical, Inc.
Methodology
LOADING...
